Click on image to view larger version.

Figure 2 (A) Cumulative probability of appropriate implantable cardioverter-defibrillator (ICD) therapy for cardiac death or ventricular tachycardia/ventricular fibrillation (VT/VF) by percentage of days that statin therapy was used (90%, 11% to 89%, and 10%) during follow-up. Numbers below each graph are the number of patients at risk in the time period; the p value assesses differences among the three curves. (B) Cumulative probability of appropriate ICD therapy for VT/VF by percentage of days that statin therapy was used (90%, 11% to 89%, and 10%) during follow-up. Numbers below each graph are the number of patients at risk in the time period; the p value assesses differences among the three curves.